Table 2.
|
|
|
Treatment |
Control |
|
|
||
---|---|---|---|---|---|---|---|---|
Comparison | Site | Date | Samples | Nymphs (SD) | Samples | Nymphs (SD) | Weight | Effect size |
1 | RI | 5/26–6/5/98 | 15 | 19.2 (0.6) | 15 | 30.3 (1.9) | 7.3 | −0.52 |
2 | RI | 6/9–6/26/98 | 15 | 22.6 (0.9) | 15 | 30.4 (1.9) | 7.4 | −0.34 |
3 | RI | 7/3–7/14/98 | 15 | 27.9 (1.2) | 15 | 30.6 (1.6) | 7.5 | −0.13 |
4 | RI | 7/16–7/24/98 | 15 | 20.1 (1.2) | 15 | 29.7 (1.6) | 7.3 | −0.45 |
5 | CT | 5/11–5/15/98 | 13 | 31 (3) | 6 | 10 (2) | 4.1 | 0.28 |
6 | CT | 5/25–6/3/98 | 16 | 160 (6) | 8 | 41 (5) | 5.0 | 0.81 |
7 | CT | 6/8–6/11/98 | 16 | 343 (34) | 8 | 67 (5) | 5.2 | 0.45 |
8 | CT | 6/22–6/29/98 | 16 | 330 (46) | 8 | 47 (7) | 5.3 | 0.38 |
9 | CT | 7/6–7/7/98 | 16 | 136 (6) | 8 | 58 (4) | 5.3 | 0.23 |
10 | CT | 7/20–7/24/98 | 16 | 51 (3) | 9 | 23 (3) | 5.7 | 0.21 |
11 | CT | 8/3–8/6/98 | 16 | 40 (3) | 9 | 43 (7) | 5.6 | −0.46 |
12 | NY | 6/4–6/11/98 | 9 | 5.1 (0.5) | 15 | 19.1 (2.4) | 5.5 | −0.35 |
13 | NY | 6/18–7/27/98 | 17 | 17.1 (0.6) | 23 | 12.1 (0.5) | 8.9 | 0.90 |
14 | NY | 7/23–9/1/98 | 18 | 29.0 (1.9) | 16 | 16.0 (1.2) | 8.3 | 0.38 |
15 | NJ | 5/19/98 | 25 | 28 (2) | 20 | 55 (4) | 10.7 | −0.56 |
16 | NJ | 5/26/98 | 25 | 86 (3) | 20 | 141 (6) | 10.4 | −0.73 |
17 | NJ | 6/1/98 | 25 | 75 (2) | 20 | 412 (69) | 10.9 | −0.38 |
18 | NJ | 6/8/98 | 25 | 49 (2) | 20 | 122 (8) | 10.4 | −0.72 |
19 | MD | 6/1/99 | 15 | 142 (10) | 15 | 297.1 (11.0) | 6.7 | −0.98 |
20 | MD | 6/8/99 | 15 | 240 (16) | 15 | 410.3 (21.3) | 7.2 | −0.58 |
21 | MD | 6/16/99 | 15 | 306 (19) | 15 | 396.4 (20.0) | 7.4 | −0.30 |
22 | MD | 6/22/99 | 15 | 153 (10) | 15 | 287.6 (10.7) | 6.9 | −0.85 |
SD, standard deviation.